SRPT:NASDAQ
Sarepta Therapeutics Inc
$17.50
arrow_downward
-0.40%(-0.070) 1D
$17.50
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
$17.75
High
$17.76
Low
$17.21
Mkt. cap
1.85B
Avg. vol.
2.97M
Volume
2.55M
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
Open
$17.75
High
$17.76
Low
$17.21
Mkt. cap
1.85B
Avg. vol.
2.97M
Volume
2.55M
52-wk high
$25.32
52-wk low
$14.69
EPS
-$1.66
Beta
0.38
Shares outstanding
105.63M
No. of employees
835
News stories
From web sources and news partners
InteractiveCrypto
·
43 minutes ago
The S&P 500 Looks Strong. Underneath, October Looks Thin.
The Motley Fool
·
5 hours ago
This Rare Market Signal Has Appeared Only 2 Times in a Century. Here Is What History Says Comes Next.
Forbes
·
2 hours ago
S&P 500 Q3 Earnings Preview: Trends Investors Need To Watch
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc